Measuring and monitoring vaccine confidence
|
|
|
- Tamsin Booker
- 5 years ago
- Views:
Transcription
1 Measuring and monitoring vaccine confidence Emilie Karafillakis Vaccine Confidence Project London School of Hygiene & Tropical Medicine IAMI Regional Meeting Madrid, 2 February
2 Man, too, is a stubborn microbe Jean Giono, The Horseman on the Roof 2
3 Confidence in vaccines Confidence in providers Confidence in systems Confidence in sexual & reproductive health interventions Director: Heidi Larson Co-director: Pauline Paterson Communication: Jay Dowle Researchers: Emilie Karafillakis, Clarissa Simas, William Schulz, Elizabeth Smout 3 PhD students: Rose Wilson, Richard Clarke, Antonis Kousoulis, Suzanne Hurst
4 Confidence crises are varied and contextspecific Childhood vaccines - Mercury MMR - Autism Polio - Sterilisation, Politics, mistrust HPV Mass fainting episodes Tetanus Sterilisation, religious beliefs 4
5 Need for quick monitoring and measurement tools Heidi J. Larson et al: Tracking the global spread of vaccine sentiments: The global response to Japan s suspension of its HPV vaccine recommendation. Human Vaccines & Immunotherapeutic 9, no 10 (2014):1-8. 5
6 Measuring vaccine confidence Understand nature and scale of waning confidence to inform appropriate interventions Monitor changes in vaccine confidence to detect and investigate drops in confidence early Use diverse types of data, combine different measurement approaches 6 Heidi Larson
7 The Vaccine Confidence Project Framework Sustaining and amplifying factors Rumour prompters Adverse Events Following Immunisation (AEFI) New research reported (e.g. Wakefield) New recommendation or policy change (e.g. removal of thimerosol from vaccines) New product (or change of current product source or packaging) Political motivations Geographic spread of rumours Frequency of rumours Media reports Historic bad experience that lowers public trust Socio-economic marginalisation (general distrust in the system ) Influencers (e.g. celebrities publicly against vaccines) Outcome/impact Vaccine refusals Vaccine suspended Vaccine preventable disease outbreaks 7 Heidi Larson
8 Theoretical framework to measure vaccine hesitancy: engagement and trust Trust toward health authorities Passive Conformism + + Enlightened conformism - + Risk culture, Healthism Passive hesitancy Rationalised hesitancy - Refusal 8 (Peretti-Watel, Plos Current Outbreaks, 2015)
9 9 Karafillakis E, et al. Vaccine hesitancy among healthcare workers in Europe: a qualitative study. Vaccine (2016). Qualitative analysis to understand drivers of change in vaccine confidence 4-country European qualitative study on HCW vaccine hesitancy (ECDC) Inconsistencies in perceptions about vaccination: praising benefits of vaccines and sharing concerns Most important concern: vaccine safety Important impact of anti-vaccination content in media Doctors have high feelings of trust in health authorities but mistrust pharmaceutical companies HCWs believe it is their role to respond to patient hesitancy
10 Understanding the gap to address it Identify key determinants of trust/distrust over time and factors that influence vaccine decision-making Isolate predictors of problems Design engagement strategies Anti-vaccine Vaccine hesitancy Immunisation as norm Pro-vaccine Where are the tipping points? 10 Heidi Larson
11 Systematic review of determinants of VH in Europe Vaccine safety Low risk of contracting VPD VPD not severe Vaccines don't work Lack information, misunderstandings Vaccines not necessary Not enough evidence, testing Not offered, recommended against Strong immune system Do not qualify Vaccines too new Too young Risks > benefits Not priority Negative media reports Against vaccination in general Natural alternatives Mistrust pharmaceutical companies Mistrust health authorities Vaccine cause the disease they prevent Mistrust governments Influenced by family/friends VPD have benefits Promiscuity, STI vaccine Concerns about injections Mistrust doctors Never had/get VPD Too many vaccines Negative experience (personal) Conflicting messages Immune system too weak VPDs not severe 51 Low risk of contracting VPDs Fear of side effects Frequency of concerns: number of qualitative studies where concerns were mentioned + number of quantitative studies where more than 20% of participants mentioned those concerns 11 Karafillakis & Larson (2015). Analysis of public concerns and perceptions related to benefits and risks of vaccines. ADVANCE D1.4 Report
12 12 Larson H, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. Ebiomedicine (2016). Surveys: the state of vaccine confidence in the world 65,819 individuals, 67 countries September-December 2015 Online, telephone, or face-to-face Four key components: 1. Vaccines are important for children to have 2. Overall, I think vaccines are safe 3. Overall, I think vaccines are effective 4. Vaccines are compatible with my religious beliefs
13 13 Larson H, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. Ebiomedicine (2016). Interactive Country Data Viewer Available at:
14 Overall, I think vaccines are safe 14 Larson H, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. Ebiomedicine (2016).
15 15 Larson H, et al. The state of vaccine confidence 2016: global insights through a 67-country survey. Ebiomedicine (2016). Main conclusions from the survey Vaccine sentiment more negative in European and West Pacific regions Western & Northern Europe > Eastern & Southern Europe USA, Canada, Mexico > South American countries Risk of transnational influences of vaccine sentiments Education does not always imply confidence Perceptions of vaccine important (higher than safety) may mitigate losses in vaccination uptake
16 Real-time media monitoring of public pulse Larson H, et al. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infectious Diseases (2013). 16
17 9/10/2015 9/12/2015 9/14/2015 9/16/2015 9/18/2015 9/20/2015 9/22/2015 9/24/2015 9/26/2015 9/28/2015 9/30/ /2/ /4/ /6/ /8/ /10/ /12/ /14/ /16/ /18/ /20/ /22/ /24/ /26/ /28/ /30/ /1/ /3/ /5/ /7/ /9/ /11/ /13/ /15/2015 Global media monitoring of HPV vaccines Global online news media (no social media) 10 September 15 November 2015, GoogleAlerts Wide search strategy around HPV vaccine with colloquial as well as scientific terms in English Before and after EMA report on HPV vaccine safety PRELIMINARY DATA DO NOT DUPLICATE - EMILIE KARAFILLAKIS
18 Themes identified by HPV media monitoring Denmark Benefits Safety EMA review Morality Not needed Mandates Japan Parent groups Industry influence Doctorpatient influence PRELIMINARY DATA DO NOT DUPLICATE - EMILIE KARAFILLAKIS
19 19
20 20 The Vaccine Confidence Project (2015). The state of vaccine confidence London: LSHTM. Measuring vaccine confidence: no single metric tells the story Hesitancy Rates & reasons Language Sentiment Analysis Real-Time Detection Socioeconomic correlates Historical, Political, Analysis Timeseries analysis of coverage
21 Sometimes the solution lies outside the vaccination programme 21 The Vaccine Confidence Project (2015). The state of vaccine confidence London: LSHTM.
22 22
The perceived full public health value of vaccines and vaccine hesitancy among patients and providers. Pauline Paterson
The perceived full public health value of vaccines and vaccine hesitancy among patients and providers Pauline Paterson Annecy, December 2016 The team at The Vaccine Confidence Project conduct global research
Vaccine hesitancy in the EU: state of play and impact on vaccination programmes
Vaccine hesitancy in the EU: state of play and impact on vaccination programmes Lucia PASTORE CELENTANO, MD, MSc Head of the Vaccine Preventable Diseases Programme, ECDC Addressing vaccine hesitancy in
Strategies to address vaccine hesitancy:
Strategies to address vaccine hesitancy: Lessons from the SAGE WG on Vaccine Hesitancy Emilie Karafillakis emilie.karafillakis@lshtm.ac.uk Les rencontres de santé publique, Paris, 7 June 2016 1 Concerns
Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health
Opinion Vaccination Programmes and Health Systems in the EU Expert Panel on Effective Ways of Investing in Health Brussels, 13 September 2018 Expert Panel on Investing in Health Access to innovative medicines
Legislative Approaches to Immunization Across the European Region
Legislative Approaches to Immunization Across the European Region December 2018 1 OUR MISSION To make life-changing vaccines more accessible, enable innovation & expand immunization across the globe. 2
Presentation to Workshop on Enhancing Communication around Influenza Vaccination Susan Goldstein June 2013
Presentation to Workshop on Enhancing Communication around Influenza Vaccination Susan Goldstein June 2013 Working Group Members Xiaofeng Liang, Chair Chinese Center for Disease Control, China Juhani Eskola
School-based HPV Immunisation Programs: The WA Experience
School-based HPV Immunisation Programs: The WA Experience Professor Paul Effler, MD, MPH, FAFPHM Medical Coordinator, Prevention and Control Program Communicable Disease Control Directorate WA School Based
Vaccine Hesitancy. Kevin Connolly. Sept. 22 nd, 2016 Limerick
Vaccine Hesitancy Kevin Connolly Sept. 22 nd, 2016 Limerick Importance of Vaccines The success of vaccines in reducing disease-associated mortality is second only to the introduction of safe drinking water
Understanding vaccine hesitancy in a post-factual era
Understanding vaccine hesitancy in a post-factual era Jonas Sivelä, Senior Researcher, PhD Infectious Disease Control and Vaccinations The Department of Health Security National Institute for Health and
Tailoring Seasonal Influenza Immunization Programmes for Health Care Workers
Tailoring Seasonal Influenza Immunization Programmes for Health Care Workers Pernille Jorgensen Influenza and other Respiratory Pathogens High-level hearing on seasonal influenza vaccination Luxembourg
Increasing the uptake of MMR in London: executive summary of findings from the social marketing project, November 2009
Increasing the uptake of MMR in London: executive summary of findings from the social marketing project, November 2009 1 Introduction & approach The London Social Marketing Unit (LSMU joined in April 2009)
Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective
Beyond vaccine introduction: Working together for sustainable, resilient immunization programs Manufacturer perspective IAIM Regional Meeting for the Americas and Europe 1 February 2017 Anupama Tantri
Vaccination uptake by vaccine hesitant parents attending a Specialist Immunisation Clinic in Australia.
Vaccination uptake by vaccine hesitant parents attending a Specialist Immunisation Clinic in Australia. Margie Danchin, Alissa McMinn, Nigel Crawford, Julie Leask, Thomas Forbes Paediatrician, Department
Volume. March Year End. Hepatitis. estimated. male. The. mean age of
COMMUNICABLE DISEASEE REPORT Quarterly Report Volume 32, Number 1 2014 Year End Summary March 2015 Hepatitis C in Newfoundland and Labrador Page 1 Enteric Outbreaks in 20144 Page 2 Vaccine Coverage Rates
EUROPEAN IMMUNIZATION WEEK APRIL Communications package
EUROPEAN IMMUNIZATION WEEK 23-29 APRIL 2018 Communications package CONTENTS BACKGROUND AND OBJECTIVE... 3 THEME... 4 KEY MESSAGES... 5 CAMPAIGN MATERIALS... 6 RESOURCES... 7 CONNECT... 8 2 BACKGROUND AND
Vaccine Hesitancy- Current Issues and Controversies including HPV vaccine. Dr Brenda Corcoran National Immunisation Office
Vaccine Hesitancy- Current Issues and Controversies including HPV vaccine Dr Brenda Corcoran National Immunisation Office What is vaccine hesitancy? An expression of concern or doubt about the value or
Vaccine Hesitancy: an international perspective
Vaccine Hesitancy: an international perspective Brickset.com Noni MacDonald 1, Sarah Lane 2, Melanie Marti 3 1. Dept Pediatrics, Dalhousie University, Canadian Centre for Vaccinology, Halifax, Canada 2.
Vaccines Work Version
Vaccines Work 2018 Version European Immunisation Week (EIW) is celebrated across the European Region every April to raise awareness of the importance of immunisation for people s health and well-being.
VACCINES FOR ADULTS. Developing an Underutilised Health Resource. 13 November 2007
VACCINES FOR ADULTS Developing an Underutilised Health Resource 13 November 2007 OUTLINE background to adult immunisation in Canada roles and recommendations of immunisation advisory committees in Canada
Accelerated Development of VAccine benefit-risk Collaboration in Europe
www.advance-vaccines.eu Accelerated Development of VAccine benefit-risk Collaboration in Europe Grant Agreement nº115557 Deliverable 1.4 Analysis of public concerns and perceptions related to WP1 Best
ISSUES RELATED TO HPV VACCINE ACCEPTANCE: LESSONS FROM THE DANISH HPV VACCINE EXPERIENCE
ISSUES RELATED TO HPV VACCINE ACCEPTANCE: LESSONS FROM THE DANISH HPV VACCINE EXPERIENCE Palle Valentiner-Branth, MD, PhD Head of VPD group Department of Infectious Disease Epidemiology & Prevention Statens
Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed
1. Background Proposal for an EU Joint Action on Vaccination: Cross-border challenges to be addressed Vaccination certainly constitutes one of the most cost-effective public health interventions implemented
Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders
Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders 1. An electronic survey was administered in April-May 2013 to 112 World Bank Task Team Leaders of Bank-supported health projects
Human Papillomavirus Vaccination Programme in Malaysia
2016/SOM3/HWG-LSIF/WKSP/010 Session Human Papillomavirus Vaccination Programme in Malaysia Submitted by: Malaysia Accelerating Action on Human Papillomavirus and Cervical Cancer Prevention and Control
Past and Present Trends in Vaccine Refusal
Past and Present Trends in Vaccine Refusal Robyn Correll Carlyle, MPH Objectives Discuss past trends in vaccine refusal and how they relate to current opposition. Describe common concerns regarding vaccination
LIFE-COURSE IMMUNISATION
LIFE-COURSE IMMUNISATION EVENT REPORT OCTOBER 2018 http://eurac.tv/9pmw With the support of LIFE-COURSE IMMUNISATION EVENT REPORT OCTOBER 2018 http://eurac.tv/9pmw In his 2017 State of the Union speech,
Executive Summary. Emergency meeting EBOLA Lessons learned from past Ebola outbreaks to inform current risk management. Dar es Salaam, Tanzania
Executive Summary Emergency meeting EBOLA Lessons learned from past Ebola outbreaks to inform current risk management Dar es Salaam, Tanzania 1st 2nd September 2014 London, Lyon, Dar, 7th September 2014
Vaccination glossary. Vaccine
Vaccination glossary Vaccine A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism,
Vaccine Hesitancy a widespread problem. Increasing vaccination uptake ECDC communication materials and pilot projects
Vaccine Hesitancy a widespread problem. Increasing vaccination uptake ECDC communication materials and pilot projects Karam ADEL ALI on behalf of ECDC Vaccine-Preventable Diseases Programme ProVacMed Network
Information resources for healthcare professionals on immunisation schedules and vaccines in EU countries
Information resources for healthcare professionals on immunisation schedules and vaccines in EU countries Tarik Derrough, Surveillance and Response Support Unit, VPD programme, European Centre for Disease
V A C C I N E H E S I TA N C Y :
V A C C I N E H E S I TA N C Y : T H E R O L E O F C O N V E N I E N C E T H E O R E T I C A L A S P E C T S A N D I S S U E S I N C A N A D A S H A N N O N M A C D O N A L D P H D, RN U N I V E R S I
Seasonal influenza vaccination Recommendations & Reality
Seasonal influenza vaccination Recommendations & Reality World Vaccine Congress, 16-18 October 2012, Lyon, France Caroline Brown Influenza and other Respiratory Pathogens WHO Regional Office for Europe
TELL ME Communication Kit
Venice, 05-12-2014 Communication Kit (Practical Guide for Risk and Outbreak Communication) British Medical Journal Publishing Group CEDARThree Instituto Superiore di Sanità Zadig Srl. 05/12/2014 1 The
Vaccine Trends Social Barometer
Vaccine Trends Social Barometer Geographic Activity for 7/1/13-7/31/13 July 2013 Monthly Activity Summary Unique Alerts Curated 929 Total Alerts (Including Duplicate Reports) 1899 Report Vaccine Sentiment
Vaccine Safety Issues
Vaccine Safety Issues Lessons from Hepatitis B Immunization Programs Mark A. Kane MD, MPH A lie can travel half way around the world while the truth is putting on its shoes. Mark Twain Anti-vaccination
Health Literacy - creating Trust in Vaccination
Health Literacy - creating Trust in Vaccination Hildrun Sundseth Board Member European Institute of Women s Health About the EIWH The European Institute of Women s Health (EIWH) is a health NGO launched
Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe
Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe Progress Toward Rubella Elimination and CRS Prevention in Europe February 8-10, 2012; Rome, Italy
The Danish childhood vaccination program SUMMARY IN ENGLISH
The Danish childhood vaccination program SUMMARY IN ENGLISH 2018 Why do we vaccinate children in Denmark? Childhood immunization programs are some of the most effective preventive public health measures
ELECTRONIC IMMUNISATION RECORD
ELECTRONIC IMMUNISATION RECORD SPECIAL REPORT 6-12 OCTOBER 2017 http://eurac.tv/9abu With the support of ELECTRONIC IMMUNISATION RECORD SPECIAL REPORT 6-12 OCTOBER 2017 http://eurac.tv/9abu Contents Commission
Theo Brandt and Jenny Royle
Having immunisation conversations and the challenges of communication Sept 7 th 2017 Wellington, NZ Theo Brandt and Jenny Royle Our perspective on diseases Diseases can be very severe Limitations in treatment
Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016
Midterm Review of the Global Measles and Rubella Strategic Plan 2012 2020 W. A. Orenstein, MD SAGE Geneva, 19 October 2016 1 Outline Strategic Plan 2012-2020 Progress toward milestones and goals Objectives
Managing public concerns. Jo Yarwood Department of Health England
Managing public concerns Jo Yarwood Department of Health England As of 12 May 2011, more than 10,000 cases of measles and four deaths have been reported from 18 European Union/European Economic Area countries
SHOULD VACCINES BE COMPULSORY?
The Big Debate SHOULD VACCINES BE COMPULSORY? Friday 02 March 2018 SHOULD VACCINES BE COMPULSORY? THE DILEMMA A change in French law means that all parents must now vaccinate children born on 1 January
Vaccination program: governance and policy decision process in Malaysia DR SAFURAH JA AFAR MINISTRY OF HEALTH MALAYSIA
Vaccination program: governance and policy decision process in Malaysia DR SAFURAH JA AFAR MINISTRY OF HEALTH MALAYSIA Objective Immunisation Program Malaysia To protect people against diseases by ensuring
Consultation on Strengthened EU cooperation against vaccine preventable diseases
Consultation on Strengthened EU cooperation against vaccine preventable diseases EuroHealthNet is a not-for-profit partnership of public bodies working from local to regional, national, and international
Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU
Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU N. Safrany European Commission Pr. A. Nicoll ECDC 2 nd WHO GAP mtg 12-14 July 2011 Background
Adult Immunization: CDC Communication Efforts and the Consumer Perspective
Adult Immunization: CDC Communication Efforts and the Consumer Perspective Kristine Sheedy, PhD Associate Director for Communication Science National Center for Immunization and Respiratory Diseases Office
Vaccine Safety: the risk of undermining our successes at the global level
Vaccine Safety: the risk of undermining our successes at the global level Pan-American Vaccine Safety Summit May 10, 2012 1 nsafe vaccine can have serious consequences Safety crises derail immunization
Vast majority of Canadians say vaccines should be mandatory for school aged kids
Vast majority of Canadians say vaccines should be mandatory for school aged kids But among those with children under 12, one-fifth say it should be up to parents whether to vaccinate February 21, 2019
Vaccine Media Trends Barometer December 2013
Vaccine Media Trends Barometer December 13 Geographic Activity Dec 1-31 13 Activity Summary December Alerts % of Total Report Vaccine Sentiment Negative 225 1.3% Neutral 92.5% Positive 137 81.2% Total
The English immunization programme
The English immunization programme Mary Ramsay Head of Immunisation Public Health England National Health Service Constitution (2009) You have the right to receive the vaccinations that the Joint Committee
Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012
Measles Containing Vaccines UNICEF Supply Division Industry Consultation Meeting 25-26 January 2012 Content Measles monovalent vaccine: Programme Updates and Procurement Overview Measles and Rubella vaccine:
The challenge of vaccine hesitancy in the European Union
The challenge of vaccine hesitancy in the European Union Michael Sulzner AIM SEMINAR Vaccine hesitancy, a global trend which threatens public health 11 December 2017, Brussels Outline - Competence - Political
VACCINES TRIUMPHS AND TRIBULATIONS. William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine
VACCINES TRIUMPHS AND TRIBULATIONS William Schaffner, MD Chairman, Department of Preventive Medicine Vanderbilt University School of Medicine Never in the history of human progress has a better and cheaper
A view from the ground what have we learned? Joanne Yarwood National Programme Manager Public Health England 1 st February 2017
A view from the ground what have we learned? Joanne Yarwood National Programme Manager Public Health England 1 st February 2017 Vaccine delivery - supply, clinics Vaccine development Communication PLANNING
The State of Measles and Rubella in the WHO European Region
The State of Measles and Rubella in the WHO European Region Mark Muscat Vaccine-preventable Diseases and Immunization Rome, Italy, 16-17 June 2016 All six WHO Regions have measles elimination goals 2 Annual
Vaccine Media Trends Barometer November 2013
Vaccine Media Trends Barometer 213 Geographic Activity Nov 1-3, 213 Activity Summary Alerts % of Total Report Vaccine Sentiment Negative 29 1.3 Neutral 259 9.2 Positive 226 8.5 Total 289 Monthly Report
Public Health Resources: Core Capacities to Address the Threat of Communicable Diseases
Public Health Resources: Core Capacities to Address the Threat of Communicable Diseases Anne M Johnson Professor of Infectious Disease Epidemiology Ljubljana, 30 th Nov 2018 Drivers of infection transmission
Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office
Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office SAGE, Geneva 27 October 2009 Rebecca Martin Targeted Diseases and
Conclusions of the high level hearing on seasonal influenza 30 April 2015, Luxembourg Michael Sulzner
Conclusions of the high level hearing on seasonal influenza 30 April 2015, Luxembourg Michael Sulzner Public Health Directorate DG Health & Food Safety 30 September 2015, Antwerp Principle of subsidiarity
Vaccine Hesitancy, Social Media and the HPV vaccine
Vaccine Hesitancy, Social Media and the HPV vaccine Eve Dubé PhD Institut national de santé publique du Québec Centre de recherche du CHU de Québec- Université Laval @DubeEve Objectives Define vaccine
Childhood Vaccination and Immunisation
DIRECTORATE GENERAL FOR INTERNAL POLICIES POLICY DEPARTMENT A: ECONOMIC AND SCIENTIFIC POLICY WORKSHOP Childhood Vaccination and Immunisation Brussels, 19 June 2013 MEETING DOCUMENT Policy Department A:
Speech by HRH Crown Princess Mary at WHO s 62nd Regional Committee Malta, September 10, 2012
Speech by HRH Crown Princess Mary at WHO s 62nd Regional Committee Malta, September 10, 2012 Your Excellency Prime Minister, Honourable Ministers, Madam Director-General, Mr. Commissioner, Mr. Deputy Secretary-General,
Subject: NHS Screening and Immunisation Programmes T
Report of the West Yorkshire Screening and Immunisation Team to the meeting of the Health and Social Care Overview & Scrutiny Committee to be held on 7 December 2017 Subject: NHS Screening and Immunisation
Immunization coverage and exemptions among Ontario s school pupils for : Findings and implications for future information systems
Immunization coverage and exemptions among Ontario s school pupils for 2011 12: Findings and implications for future information systems GH Lim, MA McIntyre, S Wilson PHO Ground Rounds August 20, 2013
Counselling the Vaccine Hesitant Parent
Counselling the Vaccine Hesitant Parent Western Canadian Immunization Forum Jane C Finlay MD, FRCPC Pediatrician BCCH Family Immunization Clinic Disclosure I have received payment for work done for the
Vaccination Lets work together. Presentation Outline. How vaccines work 22/08/2018. Dr Fiona Ryan IPC Course September 2018.
Vaccination Lets work together Dr Fiona Ryan IPC Course September 2018 Presentation Outline How vaccines work Healthcare worker vaccinations Measles HCWs as promoters of vaccines HPV How vaccines work
Barriers and drivers of seasonal influenza vaccination coverage in the EU. Elisabeth Nicand
Barriers and drivers of seasonal influenza vaccination coverage in the EU Elisabeth Nicand enicand@mesvaccins.net National Influenza schedule in Europe (www.ecdc/ vaccine scheduler) Influenza vaccination
Mobilize, Deliver, Sustain: Lessons learnt and practical advice for effective HPV vaccine delivery in low- and middle-income countries
Mobilize, Deliver, Sustain: Lessons learnt and practical advice for effective HPV vaccine delivery in low- and middle-income countries Deborah Watson-Jones, Katherine Gallagher, Carol Tevi-Benissan and
RECOMMENDED CITATION: Pew Research Center, February 2015, 83% Say Measles Vaccine Is Safe for Healthy Children
NUMBERS, FACTS AND TRENDS SHAPING THE WORLD FOR RELEASE FEBRUARY 9, 2015 FOR FURTHER INFORMATION ON THIS REPORT: Carroll Doherty, Director of Political Research Seth Motel, Research Analyst Rachel Weisel,
e-bug: Vaccinations Teacher Sheet Student worksheet 1 answers
Student worksheet 1 answers 1. The table below provides the percentage of children immunised by their second birthday against measles, mumps and rubella (MMR) between 1996 and 2014 (England only). This
Vaccine confidence in Europe: time for action
Seminar report Vaccine confidence in Europe: time for action 7 November 2018, Brussels, Belgium This report summarises the presentations and discussions of the vaccine confidence seminar that was organised
Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )
Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies
Running Head: PARENTAL ATTITUDES & CHILDHOOD VACCINES 1
Running Head: PARENTAL ATTITUDES & CHILDHOOD VACCINES 1 Parental Attitudes Toward Childhood Vaccinations: Influences on Decision Making Final Project Stacey Chun Public Administration 706:Applied Data
Measles and Rubella Global Update SAGE 19 October 2017
Measles and Rubella Global Update SAGE 19 October 2017 Alya Dabbagh WHO HQ, IVB/EPI Global update Overview Regional progress and challenges M&RI Midterm Review updates Economics of measles and rubella
Towards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
Vaccine Hesitancy in Alberta
Vaccine Hesitancy in Alberta Dr. Judy MacDonald Medical Officer of Health Alberta Health Services - Calgary June 12, 2012 Disclosure No conflicts of interest to declare Member of Alberta Advisory Committee
Social Determinants of Health
1. Background Social Determinants of Health Despite major improvements in life expectancy and health outcomes globally, health inequities remain a significant and in many cases growing challenge. While
Communication. Vaccine Prevention of a Rare but Severe Disease
http://www.austincc.edu/ microbio/2704r/nm.htm Communication Issues Noni MacDonald MD MSc FRCPc FCAHS Professor of Paediatrics (Infectious Diseases) Dalhousie University, Canadian Centre for Vaccinology
Workshop 5: HPV vaccination programs in Europe, lessons learnt and the way forward.
Workshop 5: HPV vaccination programs in Europe, lessons learnt and the way forward. Alex Vorsters & Pierre Van Damme HPV prevention and control board Centre for the evaluation of vaccination Vaccine and
Proposal. Equity-based childhood immunization policy-making in urban centres across Canada: A comparative analysis
Equity-based childhood immunization policy-making in urban centres across Canada: A comparative analysis Proposal Thilina Bandara Tsb488@mail.usask.ca 1 Table of Contents 1.) Introduction... 2 2.) Objective
Policy Document. Vaccination Policy. Background
Policy Document Vaccination Policy Background The Australian Medical Students Association (AMSA) is the peak representative body of Australia s medical students. AMSA believes that all communities have
Updates from the European Centre for Disease Prevention and Control
Updates from the European Centre for Disease Prevention and Control AIRA 2018 National Meeting, Salt Lake City Global Perspectives Plenary session Tarik Derrough Senior Expert Vaccine Preventable Diseases
Çeşme Izmir, Turkey, September 2013
Regional Committee for Europe Sixty-third session Çeşme Izmir, Turkey, 16 19 September 2013 İZKA/ Tamer Hartevioğlu Progress report on measles and rubella elimination and the package for accelerated action
Vaccination at school future challenges
Vaccination at school future challenges Dr Claire Cameron Epidemiologist (Immunisation) Health Protection Scotland Prevention and control of viral hepatitis through adolescent health programmes in Europe
Lessons learned and strategies for maintaining measles elimination Alberta s perspective
Lessons learned and strategies for maintaining measles elimination Alberta s perspective Martin Lavoie, MD, FRCPC Deputy Chief Medical Officer of Health Government of Alberta Disclosure Statement Martin
Current issues with variability in vaccine uptake and what can be done to improve it
Current issues with variability in vaccine uptake and what can be done to improve it 21 June 2018 Dr Vanessa Saliba Consultant Epidemiologist National Infection Service Content Inequalities - legal and
Pneumococcal polysaccharide vaccine uptake in England, , prior to the introduction of a vaccination programme for older adults
Journal of Public Health Advance Access published July 7, 2006 Journal of Public Health pp. 1 of 6 doi:10.1093/pubmed/fdl017 Pneumococcal polysaccharide vaccine uptake in England, 1989 2003, prior to the
Changing the prevention paradigm for the future what Europe can do
November 3rd, 2014 Honorable Beatrice Lorenzin, Minister of Health of Italy Italian Presidency of the EU Council Conference/Meeting The State of Health of Vaccination in the EU: where do we stand, where
HPV, Cancer and the Vaccination Programme
HPV, Cancer and the Vaccination Programme Dr Brenda Corcoran Consultant in Public Health Medicine HSE National Immunisation Office What is HPV? Human papillomavirus Over 200 types identified Spread by
4.0 Prevention of Infection Vaccines
4.0 Prevention of Infection Vaccines National Curriculum Link Key Stage 3 Sc1:1a - 1c. 2a 2p Sc2: 2n, 5c, 5d Unit of Study Unit 8: Microbes and Disease Unit 9B: Fit and Healthy Unit 20: 20 th Century Medicine
Challenges of building a new vaccine delivery platform for LMICs
Challenges of building a new vaccine delivery platform for LMICs Terri B. Hyde, MD MPH Immunizations Systems Branch, GID, CDC 23 March 2017 Immunization in the Elderly Geneva, Switzerland What has been
The Workings of Outbreak Response in Refugee Communities
The Workings of Outbreak Response in Refugee Communities ABC News Victoria Hall Epidemic Intelligence Service Officer 11 th Annual Local Public Health and Resettlement Agency Forum January 25, 2018 If
Immunization Update. Jim Taylor University of Washington
Immunization Update Jim Taylor University of Washington definition Vaccines biologic agents administered to promote an immune response and treat or prevent disease 2 Vaccines One of few medical interventions
Poliomyelitis eradication in the WHO European Region
Provisional agenda item 6(i) EUR/RC60/16 (+EUR/RC60/Conf.Doc./9) 23 July 2010 101614 ORIGINAL: ENGLISH Poliomyelitis eradication in the WHO European Region WHO Regional Committee for Europe Sixtieth session
The schedule for childhood vaccination is:(web link to NHS Childhood Immunisation Schedule for 2008
Immunisations and vaccinations Immunisation is an effective public health intervention for promoting good health and protecting individuals and populations against serious disease and infection through
Identifying Barriers to Cervical Cancer Screening Faced by South Asian Muslim Immigrant Women in Calgary
Identifying Barriers to Cervical Cancer Screening Faced by South Asian Muslim Immigrant Women in Calgary Syeda Kinza Rizvi Supervisor: Dr. James Dickinson Committee Members: Dr. M Hebert, Dr. B Thomas
Maternal perceptions of childhood vaccination: reasons for and against
Maternal perceptions of childhood vaccination: reasons for and against By: Melissa Mueller Student BA Honours Psychology BA Communications Studies University of Calgary Disclosure Statement I have no affiliation
Highland NHS Board 6 October 2015 Item 5.1 NEW VACCINATION PROGRAMMES
Highland NHS Board 6 October 2015 Item 5.1 NEW VACCINATION PROGRAMMES Report by Abhayadevi Tissington, Nurse Consultant Health Protection and Ken Oates, Consultant in Public Health on behalf of Hugo Van
Methodologies for vaccine safety surveillance. Nick Andrews, Statistics Unit Public Health England October 2015
Methodologies for vaccine safety surveillance Nick Andrews, Statistics Unit Public Health England October 2015 Some dramas of the past 20 years which do you think turned out to be real adverse reactions?